HopeStage
Back to all studies
RecruitingNCT06507787

EDIT-B blood test to guide care for depression and bipolarity

About this titleRead the official source — NCT06507787
Study assessmentsAges 18–65France
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Erstein and 6 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 3, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
450
Sponsor
Alcediag
Sponsor type
Unknown or unclear
Study type
Diagnostic Test
Intervention type
DIAGNOSTIC_TEST
Study phase
Not clearly listed
Locations
France
Age range
From 18 Years to 65 Years
Official registry ID
NCT06507787
Official title
Show the full official title

Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects

Recruitment & locations

Recruiting

Erstein · Issy-les-Moulineaux · La Roche-sur-Foron

4 more locations
  • Lyon
  • Montrond-les-Bains
  • Paris
  • Ville-d'Avray

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Alcediag.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies